Cefuroxime Sterile Ophthalmic Injection Recalled Due to Sterility Concerns
Edge Pharma is recalling Cefuroxime sterile ophthalmic solution for injection because the company cannot assure the product meets sterility requirements. The recall affects approximately 1,720 syringes distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall. The hazard—lack of sterility assurance in an intraocular injection product—creates a direct risk of serious infection in a high-risk medical procedure, warranting a Severe classification per the rubric for FDA Class II recalls with serious potential consequences.
Plain-English summary
Edge Pharma, LLC is recalling Cefuroxime, Sterile Ophthalmic Solution for Injection (3mg/0.3mL, 10 mg/mL), 0.3 mL single-use syringes for intraocular injection due to a lack of assurance of sterility. The affected product has NDC number 05446-1003-01 and was distributed nationwide. Approximately 1,720 syringes are included in this recall.
The specific lot codes affected are: 08-2021-30@1 with expiration date 12/20/2021; 09-2021-21@5 with expiration date 01/03/2022; and 10-2021-18@5 with expiration date 02/07/2022.
Cefuroxime is an antibiotic injection used in eye surgery. If this product does not meet sterility assurance requirements, it poses a potential risk of infection to patients receiving intraocular injection. Patients and healthcare providers who have received or administered this product should contact Edge Pharma or consult their healthcare provider for guidance.
The recalled product
- Product
- Cefuroxime, Sterile Ophthalmic Solution for Injection, Preservative Free, 3mg/0.3mL (10 mg/mL), 0.3 mL single use syringe for Intraocular Injection, Edge Pharma, LLC, 656 Hercules Dr., Colchester, VT 05446 NDC 05446-1003-01
- Manufacturer
- Edge Pharma, LLC
- Category
- Drug — Ophthalmic Injectable
- Affected units
- 1,720
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 08-2021-30@1 12/20/2021
- 09-2021-21@5 01/03/2022 & 10-2021-18@5 02/07/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 56 recalled by Edge Pharma, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 56 products in this recall →Related recalls
Same manufacturer · Edge Pharma, LLC
See all →- ModerateProfound-PE Dental Gel Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-02
- SevereMVASI Sterile Ophthalmic Solution Lacks Assured Sterility
FDA (Drugs) · 2022-02-02
- ModerateLET Topical Gel drug recall for CGMP deviations
FDA (Drugs) · 2022-02-02
- SevereVancomycin HCl Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2022-02-02
- ModerateCSF-HC Otic Powder Drug Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-02
Same hazard · sterility assurance failure
See all →- HighDELFLEX Peritoneal Dialysis Solution bags recalled for sterility risk
FDA (Drugs) · 2026-05-13
- SevereTirzepatide/Cyanocobalamin Injectable Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2025-07-02
- HighOmnicell IVX Station Reconstitution Transfer Sets Recall
FDA (Devices) · 2025-04-16
- HighCompounded Fentanyl and Bupivacaine Epidural Injections Recalled for Sterility Assurance
FDA (Drugs) · 2025-04-02
- HighHYDROmorphone Injectable Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2024-04-03